Skip to content

Comparison of Two Marketed Lenses in a Controlled Environment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02212301
Enrollment
45
Registered
2014-08-08
Start date
2014-07-31
Completion date
2014-12-31
Last updated
2016-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Dryness

Brief summary

This study is comparing two silicone hydrogel contact lenses in a controlled environment for identification of characteristics associated to vision.

Interventions

DEVICEsenofilcon A

Each study contact lens will be worn as daily wear modality for a period of 2 weeks each.

Each study contact lens will be worn as daily wear modality for a period of 2 weeks each.

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. The subject must be 18 years of age and less than 51 years of age; 2. The subject must have read and understood the Participant Information Sheet; 3. The subject must have read, signed and dated the Informed Consent; 4. The subject must be a current planned replacement soft contact lens wearer; 5. The subject must be a regular user of devices (computer, tablet and/or smart phone) for a minimum average of 5 ± 1 hours per day in a typical week 6. The subject must have a refractive error within the range of correction of both study contact lenses; 7. The subject must have a best-corrected visual acuity of 6/9 (20/30, 0.18 LogMAR) or better in each eye; 8. The subject must demonstrate an acceptable fit with both study contact lenses; 9. The subject must agree to wear their contact lenses as directed for the duration of the study (every day or for at least a minimum of five days per week for a minimum of six hours per day and be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule; 10. The subject must have normal eyes with the exception of the need for visual correction.

Exclusion criteria

1. Any known sensitivity or intolerance to any of the contact lenses or adjunct products to be used. 2. Monocular vision (only one eye with functional vision or only one eye fitted with contact lenses). 3. Use of systemic or ocular concomitant medications which, as determined by the investigator, might contraindicate or interfere with contact lens wear. 4. Ocular anterior segment infection, inflammation, abnormality, or active disease, which would contraindicate contact lens wear. 5. Any moderate or severe ocular condition observed during slit lamp examination at the enrollment visit. 6. A history of herpetic keratitis, ocular surgery or irregular cornea(s). 7. Known pregnancy or lactation during the study period. 8. Enrollment of investigator's office staff, relatives, or members of their respective households. 9. Participation in any clinical trial within 30 days of the enrollment visit.

Design outcomes

Primary

MeasureTime frameDescription
Tear Film Kinetics8 hour post insertionThe non-invasive tear film break-up-time (NIBUT) is the time elapsed (in seconds) between eye opening after a blink, and the appearance of the first dark spot within the tear film when observed with the wide diffuse light source of the Tearscope. This measurement is indicative of the tear film stability and the on eye wettability of contact lenses.
Time Controlled Visual Acuity8 hours post insertionThe Time Controlled Visual Acuity test is a proprietary test part of MG Vision Advanced Visual Performance Assessment. The test for distance vision is carried out at 4m under high contrast and dim luminance. The test is presented on a fast response 17 LCD screen (1280 by 1064). The test for intermediate vision is carried out at 64cm under high contrast dim luminance. The test was presented on a fast response 13.3 LCD screen (3200 by 1800). Visual acuity will be measured in a controlled environment using logMAR units.

Countries

United Kingdom

Participant flow

Pre-assignment details

A total of 45 subjects were enrolled into this study. Of the enrolled subjects 43 were dispensed and 2 subjects did not meet the eligibility criteria. Of the 43 dispensed subjects, 1 subject was discontinued 42 subjects completed the study.

Participants by arm

ArmCount
Dispensed Subjects
All subjects that were dispensed at least one lens throughout the duration of the study.
43
Total43

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1Lost to Follow-up01

Baseline characteristics

CharacteristicDispensed Subjects
Age, Continuous35.1 Years
STANDARD_DEVIATION 7.78
Region of Enrollment
United Kingdom
43 participants
Sex: Female, Male
Female
29 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 434 / 43
serious
Total, serious adverse events
0 / 430 / 43

Outcome results

Primary

Tear Film Kinetics

The non-invasive tear film break-up-time (NIBUT) is the time elapsed (in seconds) between eye opening after a blink, and the appearance of the first dark spot within the tear film when observed with the wide diffuse light source of the Tearscope. This measurement is indicative of the tear film stability and the on eye wettability of contact lenses.

Time frame: 8 hour post insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation (per-protocol). One subjects was excluded from the analysis population due to a major protocol deviation.

ArmMeasureValue (MEAN)Dispersion
Senofilcon ATear Film Kinetics5.590 SecondsStandard Deviation 4.2705
Lotrafilcon BTear Film Kinetics6.941 SecondsStandard Deviation 6.1257
Primary

Time Controlled Visual Acuity

The Time Controlled Visual Acuity test is a proprietary test part of MG Vision Advanced Visual Performance Assessment. The test for distance vision is carried out at 4m under high contrast and dim luminance. The test is presented on a fast response 17 LCD screen (1280 by 1064). The test for intermediate vision is carried out at 64cm under high contrast dim luminance. The test was presented on a fast response 13.3 LCD screen (3200 by 1800). Visual acuity will be measured in a controlled environment using logMAR units.

Time frame: 8 hours post insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation. The analysis was conducted for each lens at both near (40cm) and far distance (4m).

ArmMeasureGroupValue (MEAN)Dispersion
Senofilcon ATime Controlled Visual AcuityDistance-0.06 LogMARStandard Deviation 0.092
Senofilcon ATime Controlled Visual AcuityIntermediate0.07 LogMARStandard Deviation 0.077
Lotrafilcon BTime Controlled Visual AcuityDistance-0.07 LogMARStandard Deviation 0.075
Lotrafilcon BTime Controlled Visual AcuityIntermediate0.06 LogMARStandard Deviation 0.074

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026